Cargando…

Cell membrane-coated nanomaterials for cancer therapy

With the development of nanotechnology, nanoparticles have emerged as a delivery carrier for tumor drug therapy, which can improve the therapeutic effect by increasing the stability and solubility and prolonging the half-life of drugs. However, nanoparticles are foreign substances for humans, are ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Shiying, Tang, Qinglai, Xiao, Minna, Tong, Xinying, Yang, Tao, Yin, Danhui, Lei, Lanjie, Li, Shisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148189/
https://www.ncbi.nlm.nih.gov/pubmed/37128288
http://dx.doi.org/10.1016/j.mtbio.2023.100633
_version_ 1785034945874362368
author Zeng, Shiying
Tang, Qinglai
Xiao, Minna
Tong, Xinying
Yang, Tao
Yin, Danhui
Lei, Lanjie
Li, Shisheng
author_facet Zeng, Shiying
Tang, Qinglai
Xiao, Minna
Tong, Xinying
Yang, Tao
Yin, Danhui
Lei, Lanjie
Li, Shisheng
author_sort Zeng, Shiying
collection PubMed
description With the development of nanotechnology, nanoparticles have emerged as a delivery carrier for tumor drug therapy, which can improve the therapeutic effect by increasing the stability and solubility and prolonging the half-life of drugs. However, nanoparticles are foreign substances for humans, are easily cleared by the immune system, are less targeted to tumors, and may even be toxic to the body. As a natural biological material, cell membranes have unique biological properties, such as good biocompatibility, strong targeting ability, the ability to evade immune surveillance, and high drug-carrying capacity. In this article, we review cell membrane-coated nanoparticles (CMNPs) and their applications to tumor therapy. First, we briefly describe CMNP characteristics and applications. Second, we present the characteristics and advantages of different cell membranes as well as nanoparticles, provide a brief description of the process of CMNPs, discuss the current status of their application to tumor therapy, summarize their shortcomings for use in cancer therapy, and propose future research directions. This review summarizes the research progress on CMNPs in cancer therapy in recent years and assesses remaining problems, providing scholars with new ideas for future research on CMNPs in tumor therapy.
format Online
Article
Text
id pubmed-10148189
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-101481892023-04-30 Cell membrane-coated nanomaterials for cancer therapy Zeng, Shiying Tang, Qinglai Xiao, Minna Tong, Xinying Yang, Tao Yin, Danhui Lei, Lanjie Li, Shisheng Mater Today Bio Review Article With the development of nanotechnology, nanoparticles have emerged as a delivery carrier for tumor drug therapy, which can improve the therapeutic effect by increasing the stability and solubility and prolonging the half-life of drugs. However, nanoparticles are foreign substances for humans, are easily cleared by the immune system, are less targeted to tumors, and may even be toxic to the body. As a natural biological material, cell membranes have unique biological properties, such as good biocompatibility, strong targeting ability, the ability to evade immune surveillance, and high drug-carrying capacity. In this article, we review cell membrane-coated nanoparticles (CMNPs) and their applications to tumor therapy. First, we briefly describe CMNP characteristics and applications. Second, we present the characteristics and advantages of different cell membranes as well as nanoparticles, provide a brief description of the process of CMNPs, discuss the current status of their application to tumor therapy, summarize their shortcomings for use in cancer therapy, and propose future research directions. This review summarizes the research progress on CMNPs in cancer therapy in recent years and assesses remaining problems, providing scholars with new ideas for future research on CMNPs in tumor therapy. Elsevier 2023-04-12 /pmc/articles/PMC10148189/ /pubmed/37128288 http://dx.doi.org/10.1016/j.mtbio.2023.100633 Text en © 2023 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review Article
Zeng, Shiying
Tang, Qinglai
Xiao, Minna
Tong, Xinying
Yang, Tao
Yin, Danhui
Lei, Lanjie
Li, Shisheng
Cell membrane-coated nanomaterials for cancer therapy
title Cell membrane-coated nanomaterials for cancer therapy
title_full Cell membrane-coated nanomaterials for cancer therapy
title_fullStr Cell membrane-coated nanomaterials for cancer therapy
title_full_unstemmed Cell membrane-coated nanomaterials for cancer therapy
title_short Cell membrane-coated nanomaterials for cancer therapy
title_sort cell membrane-coated nanomaterials for cancer therapy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148189/
https://www.ncbi.nlm.nih.gov/pubmed/37128288
http://dx.doi.org/10.1016/j.mtbio.2023.100633
work_keys_str_mv AT zengshiying cellmembranecoatednanomaterialsforcancertherapy
AT tangqinglai cellmembranecoatednanomaterialsforcancertherapy
AT xiaominna cellmembranecoatednanomaterialsforcancertherapy
AT tongxinying cellmembranecoatednanomaterialsforcancertherapy
AT yangtao cellmembranecoatednanomaterialsforcancertherapy
AT yindanhui cellmembranecoatednanomaterialsforcancertherapy
AT leilanjie cellmembranecoatednanomaterialsforcancertherapy
AT lishisheng cellmembranecoatednanomaterialsforcancertherapy